Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

Shanghai Stock Exchange 603168.SS

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2023: 55.33%

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Gross Profit Margin is 55.33% for the year ending December 31, 2023, a -5.47% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2022 was 58.53%, a -9.01% change year over year.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2021 was 64.33%, a 32.43% change year over year.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2020 was 48.57%, a -26.68% change year over year.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. Gross Profit Margin for the year ending December 31, 2019 was 66.25%, a -8.14% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shanghai Stock Exchange: 603168.SS

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.

CEO	Mr. Mingxiong Huang
IPO Date	July 2, 2014
Location	China
Headquarters	No. 1588 Xinming Road
Employees	1,385
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antipyretic and analgesic, antibacterial anti-inflammatory, endocrine, auxiliary, cardiovascular, detoxification, diuretic row stone, gynecology, and infusion categories. It offers its products in injections, oral solutions, eye drops, tablets, capsules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 1978 and is based in Pinghu, China.

Key trends

Past 5 years